ORTHOFIX MEDICAL INC (OFIX)
US68752M1080 - Common Stock
We assign a fundamental rating of 3 out of 10 to OFIX. OFIX was compared to 193 industry peers in the Health Care Equipment & Supplies industry. OFIX has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, OFIX is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
OFIX had positive earnings in the past year.
In the past year OFIX has reported a negative cash flow from operations.
OFIX had negative earnings in 4 of the past 5 years.
In multiple years OFIX reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of OFIX (-16.35%) is comparable to the rest of the industry.
OFIX has a better Return On Equity (-25.28%) than 60.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -16.35% | ||
| ROE | -25.28% | ||
| ROIC | N/A |
ROA(3y)-9.57%
ROA(5y)-6.8%
ROE(3y)-14.18%
ROE(5y)-10.11%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 65.13%, OFIX is in the better half of the industry, outperforming 67.36% of the companies in the same industry.
In the last couple of years the Gross Margin of OFIX has declined.
OFIX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 65.13% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.57%
GM growth 5Y-3.71%
2. Health
2.1 Basic Checks
OFIX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OFIX has been increased compared to 1 year ago.
The number of shares outstanding for OFIX has been increased compared to 5 years ago.
Compared to 1 year ago, OFIX has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.45, we must say that OFIX is in the distress zone and has some risk of bankruptcy.
OFIX has a Altman-Z score of 1.45. This is comparable to the rest of the industry: OFIX outperforms 52.33% of its industry peers.
OFIX has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.19, OFIX perfoms like the industry average, outperforming 51.30% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.45 |
ROIC/WACCN/A
WACC9.43%
2.3 Liquidity
OFIX has a Current Ratio of 2.54. This indicates that OFIX is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.54, OFIX is not doing good in the industry: 60.62% of the companies in the same industry are doing better.
OFIX has a Quick Ratio of 1.20. This is a normal value and indicates that OFIX is financially healthy and should not expect problems in meeting its short term obligations.
OFIX has a Quick ratio of 1.20. This is in the lower half of the industry: OFIX underperforms 76.17% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.54 | ||
| Quick Ratio | 1.2 |
3. Growth
3.1 Past
The earnings per share for OFIX have decreased strongly by -26.67% in the last year.
The earnings per share for OFIX have been decreasing by -64.57% on average. This is quite bad
The Revenue has grown by 43.54% in the past year. This is a very strong growth!
Measured over the past years, OFIX shows a quite strong growth in Revenue. The Revenue has been growing by 10.51% on average per year.
EPS 1Y (TTM)-26.67%
EPS 3Y-65.8%
EPS 5Y-64.57%
EPS growth Q2Q210%
Revenue 1Y (TTM)43.54%
Revenue growth 3Y22.46%
Revenue growth 5Y10.51%
Revenue growth Q2Q7.65%
3.2 Future
Based on estimates for the next years, OFIX will show a very strong growth in Earnings Per Share. The EPS will grow by 507.68% on average per year.
OFIX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.45% yearly.
EPS Next Y-4639%
EPS Next 2Y399.9%
EPS Next 3Y507.68%
EPS Next 5YN/A
Revenue Next Year6.67%
Revenue Next 2Y6.86%
Revenue Next 3Y7.45%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 68.18 indicates a quite expensive valuation of OFIX.
Compared to the rest of the industry, the Price/Earnings ratio of OFIX indicates a somewhat cheap valuation: OFIX is cheaper than 68.91% of the companies listed in the same industry.
OFIX is valuated expensively when we compare the Price/Earnings ratio to 28.15, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 60.02 indicates a quite expensive valuation of OFIX.
67.36% of the companies in the same industry are more expensive than OFIX, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of OFIX to the average of the S&P500 Index (20.20), we can say OFIX is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 68.18 | ||
| Fwd PE | 60.02 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as OFIX's earnings are expected to grow with 507.68% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y399.9%
EPS Next 3Y507.68%
5. Dividend
5.1 Amount
No dividends for OFIX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ORTHOFIX MEDICAL INC
NASDAQ:OFIX (5/17/2024, 7:17:37 PM)
After market: 15 0 (0%)15
-0.11 (-0.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap561.15M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 68.18 | ||
| Fwd PE | 60.02 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -16.35% | ||
| ROE | -25.28% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 65.13% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.54 | ||
| Quick Ratio | 1.2 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-26.67%
EPS 3Y-65.8%
EPS 5Y
EPS growth Q2Q
EPS Next Y-4639%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)43.54%
Revenue growth 3Y22.46%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y